129 related articles for article (PubMed ID: 10331009)
1. T-cell development and susceptibility to cyclosporine A-induced autoimmunity in MHC-matched bone marrow/thymus chimeras.
Damoiseaux J; van de Gaar J; van der Heijden H; van Breda Vriesman P
Transplant Proc; 1999 May; 31(3):1579-80. PubMed ID: 10331009
[No Abstract] [Full Text] [Related]
2. Separation of major histocompatibility complex (MHC) and non-MHC gene effects in the development of T cell subsets in relation to susceptibility to cyclosporine A-induced autoimmunity.
Damoiseaux JG; Beijleveld LJ; van Breda Vriesman PJ
Transplant Proc; 1997 May; 29(3):1690-1. PubMed ID: 9142234
[No Abstract] [Full Text] [Related]
3. Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat.
Damoiseaux JG; Beijleveld LJ; Schuurman HJ; van Breda Vriesman PJ
Transplantation; 1996 Oct; 62(7):994-1001. PubMed ID: 8878395
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation.
Homma M; Damoiseaux JG; van Breda Vriesman PJ
Transplant Proc; 1997 May; 29(3):1743-4. PubMed ID: 9142256
[No Abstract] [Full Text] [Related]
5. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines.
Bridoux F; Badou A; Saoudi A; Bernard I; Druet E; Pasquier R; Druet P; Pelletier L
J Exp Med; 1997 May; 185(10):1769-75. PubMed ID: 9151702
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune-mediated vasculopathy.
Chen W; Thoburn CJ; Miura Y; Sommer M; Hruban R; Qian Z; Baldwin W; Hess AD
Clin Immunol; 2001 Jul; 100(1):57-70. PubMed ID: 11414746
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the T cell repertoire for myelin basic protein in thymus-grafted and other types of chimera: evidence that major histocompatibility complex molecules on accessory cells rather than T cell specificity mainly regulate susceptibility to autoimmune encephalomyelitis.
Matsumoto Y; Kawai K; Fujiwara M
Eur J Immunol; 1990 Sep; 20(9):2119-26. PubMed ID: 1698640
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of inducer/effector cell generation in the thymus in cyclosporine-induced autoimmunity.
Wodzig KW; Majoor GD; van Breda Vriesman PJ
Transplant Proc; 1993 Oct; 25(5):2819-21. PubMed ID: 8212247
[No Abstract] [Full Text] [Related]
9. A dominant role for non-MHC gene effects in susceptibility to cyclosporin A (CsA)-induced autoimmunity.
Damoiseaux JG; Beijleveld LJ; van Breda Vriesman PJ
Clin Exp Immunol; 1998 Sep; 113(3):333-8. PubMed ID: 9737659
[TBL] [Abstract][Full Text] [Related]
10. Patterns of MHC antigenic modulation in cyclosporine-induced autoimmunity. Implications for pathogenesis.
Parfrey NA; Prud'homme GJ
Am J Pathol; 1990 Feb; 136(2):479-86. PubMed ID: 2305838
[TBL] [Abstract][Full Text] [Related]
11. Autoreactive T-Cell subsets in acute and chronic syngeneic graft-versus-host disease.
Hess A; Thoburn C; Chen W; Horwitz L
Transplant Proc; 2001; 33(1-2):1754-6. PubMed ID: 11267499
[No Abstract] [Full Text] [Related]
12. Cyclosporine-induced autoimmunity in rats carrying thymus allografts.
Babcock SK; Niswender K; Wilson DB; Bellgrau D
Transplantation; 1990 Aug; 50(2):278-81. PubMed ID: 2382294
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to cyclosporin A-induced autoimmunity: strain differences in relation to autoregulatory T cells.
Barendrecht MM; Tervaert JW; van Breda Vriesman PJ; Damoiseaux JG
J Autoimmun; 2002 Feb; 18(1):39-48. PubMed ID: 11869045
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II-dependent autoaggression.
Hess AD; Fischer AC; Horwitz LR; Laulis MK
Transplant Proc; 1993 Oct; 25(5):2811-3. PubMed ID: 8212244
[No Abstract] [Full Text] [Related]
15. Pathogenesis of cyclosporin A-induced autoimmunity: absence of T-cell reactivity towards syngeneic antigen presenting cells.
Damoiseaux JG; van Breda Vriesman PJ
Autoimmunity; 1998; 27(1):45-56. PubMed ID: 9482206
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin-induced autoimmunity: a role for marrow-derived cells presenting self antigens in the thymus.
Babcock SK; Georgiu H; Kotzin B; Bellgau D
Transplant Proc; 1989 Feb; 21(1 Pt 1):220-1. PubMed ID: 2650108
[No Abstract] [Full Text] [Related]
17. Susceptibility to clinically manifest cyclosporine A (CsA)-induced autoimmune disease is associated with interferon-gamma (IFN-gamma)-producing CD45RC+RT6- T helper cells.
Beijleveld LJ; Groen H; Broeren CP; Klatter FA; Kampinga J; Damoiseaux JG; van Breda Vriesman PJ
Clin Exp Immunol; 1996 Sep; 105(3):486-96. PubMed ID: 8809139
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility and resistance to cyclosporin A-induced autoimmunity in rats.
Wodzig KW; Majoor GD; Van Breda Vriesman PJ
Autoimmunity; 1993; 16(1):29-37. PubMed ID: 8136464
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
20. Partial deletion of donor T cells in the recipient thymus in fully xenogeneic mouse-to-rat chimeras.
Mohiuddin MM; Qian X; Qin Y; DiSesa VJ
Transplant Proc; 2000 Aug; 32(5):1039. PubMed ID: 10936341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
